港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请

智通财经04-30

智通财经APP获悉，科笛-B(02487)涨超8%，截至发稿，涨8.46%，报7.95港元，成交额1175.14万港元。消息面上，科笛今日宣布，已向中国香港政府卫生署提交CU-40102（外用非那雄胺喷雾剂）新药上市申请（NDA）。据悉，CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品，也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指，CU-40102...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2431388779?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-30 10:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2431388779","market":"us","top_or_hot":-1,"title":"港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，科笛-B(02487)涨超8%，截至发稿，涨8.46%，报7.95港元，成交额1175.14万港元。消息面上，科笛今日宣布，已向中国香港政府卫生署提交CU-40102（外用非那雄胺喷雾剂）新药上市申请（NDA）。据悉，CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品，也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指，CU-40102...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1116046.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 科笛-B(02487)涨超8% 治疗脱发产品CU-40102于香港提交新药上市申请\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-30 10:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1116046.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，科笛-B(02487)涨超8%，截至发稿，涨8.46%，报7.95港元，成交额1175.14万港元。消息面上，科笛今日宣布，已向中国香港政府卫生署提交CU-40102（外用非那雄胺喷雾剂）新药上市申请（NDA）。据悉，CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品，也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指，CU-40102...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1116046.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YINN","symbol_name":"三倍做多富时中国ETF-Direxion","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1116046.html","article_id":"2431388779","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2431388779","pubTimestamp":1714442587,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，科笛-B(02487)涨超8%，截至发稿，涨8.46%，报7.95港元，成交额1175.14万港元。消息面上，科笛今日宣布，已向中国香港政府卫生署提交CU-40102（外用非那雄胺喷雾剂）新药上市申请（NDA）。据悉，CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品，也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指，CU-40102有望成为国内首个外用非那雄胺产品，改良优势明显。方正证券认为，公司重磅管线外用非那雄胺为首家且唯一外用非那雄胺，长期空间有望达15亿+。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"YINN":"三倍做多富时中国ETF-Direxion","BK1161":"生物科技","BK4585":"ETF&股票定投概念","YANG":"三倍做空富时中国ETF-Direxion","02487":"科笛-B","BK4588":"碎股","07226":"XL二南方恒科"},"translate_title":"Hong Kong stocks changed Kedi-B (02487) rose more than 8%, and the hair loss product CU-40102 submitted a new drug listing application in Hong Kong","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02487":1,"07226":1,"YANG":1,"YINN":1},"content_text":"智通财经APP获悉，科笛-B(02487)涨超8%，截至发稿，涨8.46%，报7.95港元，成交额1175.14万港元。消息面上，科笛今日宣布，已向中国香港政府卫生署提交CU-40102（外用非那雄胺喷雾剂）新药上市申请（NDA）。据悉，CU-40102是全球首个亦是唯一一个获批用于雄激素性脱发治疗的外用非那雄胺产品，也是首个获得国家药监局受理NDA的外用非那雄胺。开源证券此前指，CU-40102有望成为国内首个外用非那雄胺产品，改良优势明显。方正证券认为，公司重磅管线外用非那雄胺为首家且唯一外用非那雄胺，长期空间有望达15亿+。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431388779"}